Lijun Xie
#300 Guangzhou Road
Nanjing, 210029, China
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Study of the mass balance, biotransformation, and safety of [ 14C]IBI351 in healthy Chinese subjects.
Journal: Journal of biomedical research
Published: October 21, 2024
Absorption, Metabolism, and Excretion of [14C]-Labeled Anaprazole: A New Proton Pump Inhibitor, After a Single Oral Administration in Healthy Chinese Male Subjects.
Journal: Clinical pharmacology in drug development
Published: March 18, 2024
Safety, tolerability, pharmacokinetics and pharmacokinetic-pharmacodynamic modeling of cetagliptin in patients with type 2 diabetes mellitus.
Journal: Frontiers in endocrinology
Published: December 21, 2023
Study of the mass balance, biotransformation and safety of [14C]SHR8554, a novel μ-opioid receptor injection, in healthy Chinese subjects.
Journal: Frontiers in pharmacology
Published: May 30, 2023
Keverprazan, a novel potassium-competitive acid blocker: Single ascending dose safety, tolerability, pharmacokinetics, pharmacodynamics and food effect in healthy subjects.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: April 25, 2023
Keverprazan, a novel potassium-competitive acid blocker: Multiple oral doses safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy subjects.
Journal: Clinical and translational science
Published: April 19, 2023
Pharmacokinetic Interaction of Anaprazole, Amoxicillin and Clarithromycin after Single-Dose Simultaneous Administration and the Effect of Adding Bismuth on Their Pharmacokinetics in Healthy Male Chinese Subjects.
Journal: European journal of drug metabolism and pharmacokinetics
Published: November 27, 2022
Effects of ilaprazole on the steady-state pharmacodynamics of clopidogrel in healthy volunteers: An open-label randomized crossover study.
Journal: Frontiers in pharmacology
Published: May 26, 2022
Pharmacokinetics, Tolerability, Safety, and Immunogenicity of LY01008 and Bevacizumab (Avastin®) in Healthy Chinese Subjects.
Journal: European journal of drug metabolism and pharmacokinetics
Published: December 19, 2021
A double-blind, randomized, placebo and positive-controlled study in healthy volunteers to evaluate pharmacokinetic and pharmacodynamic properties of multiple oral doses of cetagliptin.
Journal: British journal of clinical pharmacology
Published: October 12, 2021
Last Updated: 09/26/2026